Burning Rock Biotech (BNR)
(Delayed Data from NSDQ)
$8.62 USD
+0.21 (2.50%)
Updated Sep 19, 2025 03:35 PM ET
After-Market: $8.51 -0.11 (-1.28%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Burning Rock Biotech Limited Sponsored ADR has a market cap of $90.50M, which represents its share price of $8.41 multiplied by its outstanding shares number of 10.76M. As a small-cap company, BNR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BNR 8.62 +0.21(2.50%)
Will BNR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BNR based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for BNR
Is BNR positioned for a breakout? Crossed Above 20 Day Moving Average shows up after rising 2.5%
BNR forms NR7 on September 18
NR7 appears for BNR after 2.59% move
Is BNR likely to continue lower? 20 Day Moving Average Resistance shows up after sliding 2.53%
20 Day Moving Average Resistance appears for BNR after 4.94% move